Medications

Counterfeit medicine a 'growing threat': EU study

Counterfeit medicine is a "growing threat" in Europe, causing serious illness or even death and costing the pharmaceutical industry billions every year, according to a study published Wednesday.

Oncology & Cancer

Drug combo slows progression in advanced breast cancer

(HealthDay)—Treatment with a combination of alpelisib and fulvestrant prolongs progression-free survival among patients with PIK3CA-mutated, hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative ...

Oncology & Cancer

High response seen for chemo in seniors with high-risk AML

(HealthDay)—A substantial proportion of older patients with high-risk acute myeloid leukemia (AML) treated with chemotherapy are long-term survivors, according to research published online June 7 in Cancer Medicine.

Medications

WHO agrees watered down resolution for clearer drug prices

The World Health Organization's member states adopted on Tuesday a watered down resolution on improving drug price transparency that leading medical charity Doctors Without Borders (MSF) criticised as insufficient.

page 2 from 2